MEANS, METHODS OF APPLICATION AND METHODS OF TREATMENT FOR SYNUCLEOPATHY

摘要

The present invention relates to new monoclonal antibodies to alpha-synuclein. Antibodies can be used to treat synucleopathy, such as Parkinson's disease (including the idiopathic and hereditary forms of Parkinson's disease), diffuse Levy's little bodies (DLBD), Alzheimer's disease with Levy's Taurus (LBV), Alzheimer's and Parkinson's combined disease, true vegetative deficiency and multiple systemic atrophy.